Mallinckrodt Receives Approval to List on NYSE American

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has...

Related Keywords

United States ,Dublin ,Ireland ,American ,Aaron Palash ,Daniel Speciale ,Michael Freitag ,Joele Frank ,Siggi Olafsson ,Prnewswire Mallinckrodt ,Derek Belz ,Wilkinson Brimmer Katcher ,Exchange Commission ,Mallinckrodt Pharmaceuticals ,Trading Of The Company ,Company Specialty Brands ,Commence Under Ticker Symbol ,Chief Executive Officer ,Current Market ,Specialty Brands ,Specialty Generics ,Investor Relations ,Private Securities Litigation Reform Act ,Financial Condition ,Annual Report ,Quarterly Reports ,Corporate Controller ,Chief Investor Relations ,Wilkinson Brimmer ,Mallinckrodt Plc ,